Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $11.7 million.

  • ENvue Medical's Total Non-Current Liabilities rose 34876.83% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 34876.83%. This contributed to the annual value of $2.8 million for FY2024, which is 1283.92% up from last year.
  • ENvue Medical's Total Non-Current Liabilities amounted to $11.7 million in Q3 2025, which was up 34876.83% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Total Non-Current Liabilities registered a high of $11.7 million during Q3 2025, and its lowest value of $712000.0 during Q3 2021.
  • For the 5-year period, ENvue Medical's Total Non-Current Liabilities averaged around $3.2 million, with its median value being $2.5 million (2023).
  • Per our database at Business Quant, ENvue Medical's Total Non-Current Liabilities tumbled by 4583.88% in 2021 and then soared by 34876.83% in 2025.
  • Over the past 5 years, ENvue Medical's Total Non-Current Liabilities (Quarter) stood at $2.1 million in 2021, then rose by 17.85% to $2.4 million in 2022, then rose by 1.9% to $2.5 million in 2023, then rose by 12.84% to $2.8 million in 2024, then skyrocketed by 318.49% to $11.7 million in 2025.
  • Its last three reported values are $11.7 million in Q3 2025, $6.8 million for Q2 2025, and $8.2 million during Q1 2025.